Department of Immunotechnology
141 – 150 of 1016
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo
- Contribution to journal › Article
-
Mark
Comprehending the proteomic landscape of ovarian cancer : A road to the discovery of disease biomarkers
- Contribution to journal › Scientific review
-
Mark
Psychological resilience and health‐related quality of life in 418 swedish women with primary breast cancer : Results from a prospective longitudinal study
- Contribution to journal › Article
-
Mark
Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy
- Contribution to journal › Scientific review
-
Mark
Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy
- Contribution to journal › Article
-
Mark
The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes
- Contribution to journal › Article
-
Mark
Stable bull fertility protein markers in seminal plasma
- Contribution to journal › Article
-
Mark
Fluorescence signal enhancement in antibody microarrays using lightguiding nanowires
- Contribution to journal › Article
-
Mark
Poorly Expressed Alleles of Several Human Immunoglobulin Heavy Chain Variable Genes are Common in the Human Population
- Contribution to journal › Article
-
Mark
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
- Contribution to journal › Article
